PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis

您当前的位置：

首页 >

文章列表页 >

PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis

Short communication | 更新时间：2023-08-29

- PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis
- PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis
- Genes & Diseases 2023年10卷第1期
- 作者机构：
  
  Department of Orthopaedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University,Shandong,Jinan,China,250021
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2022.01.005
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-1-1，
扫描看全文
PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis[J]. Genes & Diseases, 2023,10(1).

Qingyu Zhang, Shun Lu, Dongsheng Zhou, et al. PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis[J]. Genes & Diseases, 2023,10(1).
PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2022.01.005.

Qingyu Zhang, Shun Lu, Dongsheng Zhou, et al. PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2022.01.005.

摘要

Abstract

关键词

Keywords

references

0

浏览量

0

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据

⁰